Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    A G Bio Systems Pvt Ltd

    A G Bio Systems Pvt Ltd is a biotechnology company established in the year 1997 to provide integrated pest management services and also indulge in research and development activ

  • No Image
    A J Organica Pvt Ltd

    AJ Organica Pvt. Ltd is a drug development company. The company has collaboration and license form YewSavin, USA. AJ is accelerating drug development which involves principles o

  • No Image
    Aarey Drugs And Pharmaceuticals Ltd

    Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of M/s. Niharika Textile and Chemicals Limited, on May 15, 1990. T

  • No Image
    Aarti Drugs Ltd

    Aarti Drugs Ltd is a part of the USD 500 million Aarti Group of Industries, Aarti Drugs Ltd (ADL) was established way back in in 1984. Since its inception, the company has estab

  • No Image
    Abaris Healthcare Pvt Ltd

    Abaris Healthcare Pvt Ltd has been founded in July 2005 by buying out the Rajpura unit of Core Healthcare Ltd. Later, the company has purchased CHL's brands namely Corflam, Clom